
LUNG vs OBIO
$LUNG vs $OBIO head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
LUNG vs OBIO: trend, levels and the market
One year to 2026-11-18, against the S&P 500 (+10.6%). Split-adjusted daily closes.
- ·Both are in uptrends, trading above their 50- and 200-day averages, so this compares two names the market is already bidding up.
- ·Both beat the market over the past year: LUNG +92.1% and OBIO +76.4%, against the S&P 500 at +10.6%.
- ·LUNG sits closer to its support, 6.2% above it at $2.52, while OBIO is 19.9% above its own at $5.96.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
LUNG vs OBIO: the quick read
- ·OBIO is the larger company by market cap ($549M vs $119M).
- ·LUNG has been more active on our scanner (123 vs 119 alerts in 30 days).
- ·LUNG has the smaller float (40.2M vs 60.8M), which tends to mean sharper, more volatile moves.
- ·Both are surgical & medical instruments & apparatus names, so this is a like-for-like comparison and sector news tends to move them together.
- ·Both stay busy on our scanner, 123 and 119 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are pulling apart today: OBIO is outperforming the other by roughly 8.8 percentage points on the session.
Objective differences only. Not investment advice.
Watching LUNG or OBIO? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing LUNG and OBIO on TheDesperateTrader.
- Is LUNG or OBIO the better stock?
- "Better" depends on your goal, and these two are not alike. OBIO is the larger company by market cap ($549M vs $119M). LUNG has been more active on our scanner (123 vs 119 alerts in 30 days). LUNG has the smaller float (40.2M vs 60.8M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between LUNG and OBIO?
- The differences that matter: OBIO is roughly 5x the size of the other by market cap ($119M vs $549M); they trade at very different share prices ($2.68 vs $7.44); LUNG sits at 73% of its 52-week range against 100% for OBIO; our scanner flagged LUNG 123 times in the last 30 days against 119 for OBIO. Everything above is measured from the latest completed session and SEC filings.
- Which of LUNG and OBIO is more active right now?
- Right now LUNG is at about 0.7x its normal volume and OBIO is at about 1.2x, so OBIO is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is LUNG or OBIO in the stronger trend?
- LUNG is above its 50-day average of $2.18 and above its 200-day average of $1.72; OBIO is above its 50-day average of $5.98 and above its 200-day average of $4.68. LUNG leads 3 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading LUNG or OBIO? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore LUNG and OBIO comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.